Dahlia Biosciences Company

Dahlia Biosciences is the next generation of multiplexed in situ single-cell RNA analysis tools for research and diagnostic applications.
DAHLIA BIOSCIENCES, INC. provides in situ single-cell RNA analysis tools for research and diagnostic applications. The company was founded in 2017 and is headquartered in San Francisco, California.

Investors

Technology: Preventive Diagnostics
Industry: Precision Medicine
Headquarters: San Francisco
Founded Date: 2017
Employees Number: 1-10
Funding Status: Seed

Visit Website
Register and Claim Ownership